M D Simpson|P Jenner|C D Marsden - JoVE Visualize

Showing results (201-210 of 938) with videos related to

Pageof 94

Sort By:

Journal of Neurology, Neurosurgery, and Psychiatry|February 1, 1977

Plasma DOPA levels and growth hormone response to levodopa in parkinsomismA Galea-Debono, P Jenner, C D Marsden, et al.

European Journal of Pharmacology|November 19, 1981

Hypophysectomy does not prevent development of striatal dopamine receptor supersensitivity induced by repeated neuroleptic treatmentP Jenner, N M Rupniak, M D Hall, et al.

Neuropharmacology|November 1, 1989

Treatment with a selective MAO B inhibitor prevents loss of dopamine in the nucleus accumbens of MPTP-treated common marmosetsS Rose, M Nomoto, E A Jackson, et al.

Annals of Neurology|September 1, 1994

Glutathione-related enzymes in brain in Parkinson's diseaseJ Sian, D T Dexter, A J Lees, et al.

European Journal of Pharmacology|May 31, 1990

1-Methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine (2'-methyl-MPTP) is less neurotoxic than MPTP in the common marmosetS Rose, M Nomoto, E A Jackson, et al.

Neuroscience Letters|May 19, 1987

Analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine as monoamine oxidase substrates: a second ring is not necessaryC Gibb, J Willoughby, V Glover, et al.

Journal of Neurology, Neurosurgery, and Psychiatry|July 1, 1988

Leukocyte glutamate dehydrogenase activity in patients with degenerative neurological disordersD Aubby, H K Saggu, P Jenner, et al.

European Neurology|January 1, 1987

Single-dose studies of a slow-release preparation of levodopa and benserazide (Madopar HBS) in Parkinson's diseaseM H Marion, F Stocchi, S L Malcolm, et al.

Journal of Neurochemistry|March 1, 1990

Mitochondrial complex I deficiency in Parkinson's diseaseA H Schapira, J M Cooper, D Dexter, et al.

Neuropharmacology|May 1, 1984

Behavioural and biochemical alterations in the function of dopamine receptors following repeated administration of L-DOPA to ratsM D Hall, D R Cooper, S Fleminger, et al.

Pageof 94

Showing results (201-210 of 938) with videos related to

Sort By:

Pageof 94

Journal of Neurology, Neurosurgery, and Psychiatry|February 1, 1977

Plasma DOPA levels and growth hormone response to levodopa in parkinsomismA Galea-Debono, P Jenner, C D Marsden, et al.

European Journal of Pharmacology|November 19, 1981

Hypophysectomy does not prevent development of striatal dopamine receptor supersensitivity induced by repeated neuroleptic treatmentP Jenner, N M Rupniak, M D Hall, et al.

Neuropharmacology|November 1, 1989

Treatment with a selective MAO B inhibitor prevents loss of dopamine in the nucleus accumbens of MPTP-treated common marmosetsS Rose, M Nomoto, E A Jackson, et al.

Annals of Neurology|September 1, 1994

Glutathione-related enzymes in brain in Parkinson's diseaseJ Sian, D T Dexter, A J Lees, et al.

European Journal of Pharmacology|May 31, 1990

1-Methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine (2'-methyl-MPTP) is less neurotoxic than MPTP in the common marmosetS Rose, M Nomoto, E A Jackson, et al.

Neuroscience Letters|May 19, 1987

Analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine as monoamine oxidase substrates: a second ring is not necessaryC Gibb, J Willoughby, V Glover, et al.

Journal of Neurology, Neurosurgery, and Psychiatry|July 1, 1988

Leukocyte glutamate dehydrogenase activity in patients with degenerative neurological disordersD Aubby, H K Saggu, P Jenner, et al.

European Neurology|January 1, 1987

Single-dose studies of a slow-release preparation of levodopa and benserazide (Madopar HBS) in Parkinson's diseaseM H Marion, F Stocchi, S L Malcolm, et al.

Journal of Neurochemistry|March 1, 1990

Mitochondrial complex I deficiency in Parkinson's diseaseA H Schapira, J M Cooper, D Dexter, et al.

Neuropharmacology|May 1, 1984

Behavioural and biochemical alterations in the function of dopamine receptors following repeated administration of L-DOPA to ratsM D Hall, D R Cooper, S Fleminger, et al.

Pageof 94